Unmodified official OCDS data retained by Tenderline for this procurement process.
Complete current OCDS release JSON
{
"id": "028388-2023",
"tag": [
"award",
"contract"
],
"bids": {
"statistics": [
{
"id": "1",
"value": 5,
"measure": "bids",
"relatedLot": "1"
},
{
"id": "6",
"value": 2,
"measure": "bids",
"relatedLot": "2"
},
{
"id": "11",
"value": 1,
"measure": "bids",
"relatedLot": "4"
},
{
"id": "16",
"value": 6,
"measure": "bids",
"relatedLot": "3"
},
{
"id": "2",
"value": 0,
"measure": "smeBids",
"relatedLot": "1"
},
{
"id": "7",
"value": 0,
"measure": "smeBids",
"relatedLot": "2"
},
{
"id": "12",
"value": 0,
"measure": "smeBids",
"relatedLot": "4"
},
{
"id": "17",
"value": 0,
"measure": "smeBids",
"relatedLot": "3"
},
{
"id": "3",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "1"
},
{
"id": "8",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "2"
},
{
"id": "13",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "4"
},
{
"id": "18",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "3"
},
{
"id": "4",
"value": 5,
"measure": "foreignBidsFromNonEU",
"relatedLot": "1"
},
{
"id": "9",
"value": 2,
"measure": "foreignBidsFromNonEU",
"relatedLot": "2"
},
{
"id": "14",
"value": 1,
"measure": "foreignBidsFromNonEU",
"relatedLot": "4"
},
{
"id": "19",
"value": 6,
"measure": "foreignBidsFromNonEU",
"relatedLot": "3"
},
{
"id": "5",
"value": 5,
"measure": "electronicBids",
"relatedLot": "1"
},
{
"id": "10",
"value": 2,
"measure": "electronicBids",
"relatedLot": "2"
},
{
"id": "15",
"value": 1,
"measure": "electronicBids",
"relatedLot": "4"
},
{
"id": "20",
"value": 6,
"measure": "electronicBids",
"relatedLot": "3"
}
]
},
"date": "2023-09-26T15:13:25+01:00",
"ocid": "ocds-h6vhtk-03e1fc",
"buyer": {
"id": "GB-FTS-322",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000738823"
}
],
"awards": [
{
"id": "028388-2023-1",
"title": "NP35923a Apixaban",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-3467",
"name": "Glenmark Pharmaceuticals Europe Ltd"
},
{
"id": "GB-FTS-4567",
"name": "Selective Supplies Ltd"
},
{
"id": "GB-FTS-93451",
"name": "Teva UK Ltd"
},
{
"id": "GB-FTS-5073",
"name": "Thornton & Ross"
},
{
"id": "GB-FTS-80784",
"name": "Viatris UK Healthcare Ltd"
}
],
"relatedLots": [
"1"
]
},
{
"id": "028388-2023-2",
"title": "NP39723a Bexarotene",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-93450",
"name": "Celix Pharma Ltd."
}
],
"relatedLots": [
"2"
]
},
{
"id": "028388-2023-3",
"title": "NP36123a Atovaquone",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-3467",
"name": "Glenmark Pharmaceuticals Europe Ltd"
}
],
"relatedLots": [
"4"
]
},
{
"id": "028388-2023-4",
"title": "NP40923a Sugammadex",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-80783",
"name": "Dr Reddy's Laboratories (UK) Ltd"
}
],
"relatedLots": [
"3"
]
}
],
"tender": {
"id": "ocds-h6vhtk-03e1fc",
"lots": [
{
"id": "1",
"title": "NP35923a Apixaban",
"status": "cancelled",
"hasOptions": false,
"description": "Supply of Apixaban tablets in a range of presentations.\nThe Authority will be awarding each product line as a multi-supplier unranked framework agreement to five (5) suppliers awarded to each line.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
}
},
{
"id": "3",
"title": "NP40923a Sugammadex",
"status": "cancelled",
"hasOptions": false,
"description": "Supply of Sugammadex solution for injection vials, in a range of presentations to NHS Scotland.\nThe Authority will be awarding each line to a single Framework Participant within the single supplier Framework Agreement.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
}
},
{
"id": "2",
"title": "NP39723a Bexarotene",
"status": "cancelled",
"hasOptions": false,
"description": "Supply of Bexarotene 75mg capsules to NHS Scotland.\nThe Authority will be awarding the product line to a single Framework Participant within the single supplier Framework Agreement.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
}
},
{
"id": "4",
"title": "NP36123a Atovaquone",
"status": "cancelled",
"hasOptions": false,
"description": "Supply of Atovaquone 750mg/5ml oral suspension sugar free to NHS Scotland.\nThe Authority will be awarding the product line to a single Framework Participant within the single supplier Framework Agreement.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "3",
"relatedLot": "3",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "2",
"relatedLot": "2",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "4",
"relatedLot": "4",
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "NP Generic Medicines Transition Tender (October 2023)",
"status": "complete",
"coveredBy": [
"GPA"
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"techniques": {
"hasFrameworkAgreement": true
},
"description": "This Procurement is for the supply of a range of Generic Medicines to health boards across NHS Scotland. The Goods have been split into four (4) individual Framework Agreements. Full details of each individual Framework Agreement is contained in section II.2 of this notice.",
"reviewDetails": "Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:\nAn economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.\nThe bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.",
"classification": {
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
"procurementMethod": "open",
"mainProcurementCategory": "goods",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-FTS-322",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"roles": [
"buyer",
"centralPurchasingBody"
],
"address": {
"region": "UKM",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"countryName": "United Kingdom",
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent"
},
"details": {
"url": "http://www.nss.nhs.scot/browse/procurement-and-logistics",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
},
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"contactPoint": {
"email": "ruaridh.armitage@nhs.scot",
"telephone": "+44 7804475952"
}
},
{
"id": "GB-FTS-3467",
"name": "Glenmark Pharmaceuticals Europe Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Watford",
"postalCode": "WD18 8YA",
"countryName": "United Kingdom",
"streetAddress": "Building 2, Croxley Green Business Park"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Glenmark Pharmaceuticals Europe Ltd"
},
"contactPoint": {
"telephone": "+44 7538794897"
}
},
{
"id": "GB-FTS-93450",
"name": "Celix Pharma Ltd.",
"roles": [
"supplier"
],
"address": {
"region": "UKI4",
"locality": "London",
"postalCode": "E16 2DQ",
"countryName": "United Kingdom",
"streetAddress": "12 Constance Street, International House"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Celix Pharma Ltd."
},
"contactPoint": {
"telephone": "+44 7795600016"
}
},
{
"id": "GB-FTS-80783",
"name": "Dr Reddy's Laboratories (UK) Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Cambridge",
"postalCode": "CB4 0PE",
"countryName": "United Kingdom",
"streetAddress": "410, Cambridge Science Park,, Milton Road, Milton,"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Dr Reddy's Laboratories (UK) Ltd"
},
"contactPoint": {
"telephone": "+44 7717467751"
}
},
{
"id": "GB-FTS-4567",
"name": "Selective Supplies Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Haywards Heath",
"postalCode": "RH16 3LB",
"countryName": "United Kingdom",
"streetAddress": "The Priory, Syresham Gardens"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Selective Supplies Ltd"
}
},
{
"id": "GB-FTS-93451",
"name": "Teva UK Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Castleford",
"postalCode": "WF10 5HX",
"countryName": "United Kingdom",
"streetAddress": "Ridings Point, Whistler Drive, Glasshoughton"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Teva UK Ltd"
},
"contactPoint": {
"telephone": "+44 7780226334"
}
},
{
"id": "GB-FTS-5073",
"name": "Thornton & Ross",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Huddersfield",
"postalCode": "HD7 5QH",
"countryName": "United Kingdom",
"streetAddress": "Linthwaite"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Thornton & Ross"
}
},
{
"id": "GB-FTS-80784",
"name": "Viatris UK Healthcare Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKH23",
"locality": "Hatfield",
"postalCode": "AL10 9UL",
"countryName": "United Kingdom",
"streetAddress": "Building 4, Trident Place, Mosquito Way"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Viatris UK Healthcare Ltd"
},
"contactPoint": {
"telephone": "+44 7586494246"
}
},
{
"id": "GB-FTS-324",
"name": "Sheriff Court House",
"roles": [
"reviewBody"
],
"address": {
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"countryName": "United Kingdom",
"streetAddress": "27 Chambers Street"
},
"details": {
"url": "https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court"
},
"identifier": {
"legalName": "Sheriff Court House"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk",
"telephone": "+44 1312252525"
}
}
],
"language": "en",
"contracts": [
{
"id": "028388-2023-1",
"title": "NP35923a Apixaban",
"value": {
"amount": 161316,
"currency": "GBP"
},
"status": "active",
"awardID": "028388-2023-1",
"dateSigned": "2023-09-26T00:00:00+01:00"
},
{
"id": "028388-2023-2",
"title": "NP39723a Bexarotene",
"value": {
"amount": 35022,
"currency": "GBP"
},
"status": "active",
"awardID": "028388-2023-2",
"dateSigned": "2023-09-26T00:00:00+01:00"
},
{
"id": "028388-2023-3",
"title": "NP36123a Atovaquone",
"value": {
"amount": 96219,
"currency": "GBP"
},
"status": "active",
"awardID": "028388-2023-3",
"dateSigned": "2023-09-26T00:00:00+01:00"
},
{
"id": "028388-2023-4",
"title": "NP40923a Sugammadex",
"value": {
"amount": 552685,
"currency": "GBP"
},
"status": "active",
"awardID": "028388-2023-4",
"dateSigned": "2023-09-26T00:00:00+01:00"
}
],
"description": "The estimated values referred to in Section II.1.5 and each Lot section of this Notice cover the forecasted spend for the duration of each individual Framework Agreement.\nFor details of individual lines awarded within a Framework Agreement/Lot contact the named person at head of notice.\n(SC Ref:745745)",
"initiationType": "tender"
}Complete JSON history (2 releases)
26 Sept 2023 · 028388-2023 · award, contract
{
"id": "028388-2023",
"tag": [
"award",
"contract"
],
"bids": {
"statistics": [
{
"id": "1",
"value": 5,
"measure": "bids",
"relatedLot": "1"
},
{
"id": "6",
"value": 2,
"measure": "bids",
"relatedLot": "2"
},
{
"id": "11",
"value": 1,
"measure": "bids",
"relatedLot": "4"
},
{
"id": "16",
"value": 6,
"measure": "bids",
"relatedLot": "3"
},
{
"id": "2",
"value": 0,
"measure": "smeBids",
"relatedLot": "1"
},
{
"id": "7",
"value": 0,
"measure": "smeBids",
"relatedLot": "2"
},
{
"id": "12",
"value": 0,
"measure": "smeBids",
"relatedLot": "4"
},
{
"id": "17",
"value": 0,
"measure": "smeBids",
"relatedLot": "3"
},
{
"id": "3",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "1"
},
{
"id": "8",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "2"
},
{
"id": "13",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "4"
},
{
"id": "18",
"value": 0,
"measure": "foreignBidsFromEU",
"relatedLot": "3"
},
{
"id": "4",
"value": 5,
"measure": "foreignBidsFromNonEU",
"relatedLot": "1"
},
{
"id": "9",
"value": 2,
"measure": "foreignBidsFromNonEU",
"relatedLot": "2"
},
{
"id": "14",
"value": 1,
"measure": "foreignBidsFromNonEU",
"relatedLot": "4"
},
{
"id": "19",
"value": 6,
"measure": "foreignBidsFromNonEU",
"relatedLot": "3"
},
{
"id": "5",
"value": 5,
"measure": "electronicBids",
"relatedLot": "1"
},
{
"id": "10",
"value": 2,
"measure": "electronicBids",
"relatedLot": "2"
},
{
"id": "15",
"value": 1,
"measure": "electronicBids",
"relatedLot": "4"
},
{
"id": "20",
"value": 6,
"measure": "electronicBids",
"relatedLot": "3"
}
]
},
"date": "2023-09-26T15:13:25+01:00",
"ocid": "ocds-h6vhtk-03e1fc",
"buyer": {
"id": "GB-FTS-322",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000738823"
}
],
"awards": [
{
"id": "028388-2023-1",
"title": "NP35923a Apixaban",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-3467",
"name": "Glenmark Pharmaceuticals Europe Ltd"
},
{
"id": "GB-FTS-4567",
"name": "Selective Supplies Ltd"
},
{
"id": "GB-FTS-93451",
"name": "Teva UK Ltd"
},
{
"id": "GB-FTS-5073",
"name": "Thornton & Ross"
},
{
"id": "GB-FTS-80784",
"name": "Viatris UK Healthcare Ltd"
}
],
"relatedLots": [
"1"
]
},
{
"id": "028388-2023-2",
"title": "NP39723a Bexarotene",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-93450",
"name": "Celix Pharma Ltd."
}
],
"relatedLots": [
"2"
]
},
{
"id": "028388-2023-3",
"title": "NP36123a Atovaquone",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-3467",
"name": "Glenmark Pharmaceuticals Europe Ltd"
}
],
"relatedLots": [
"4"
]
},
{
"id": "028388-2023-4",
"title": "NP40923a Sugammadex",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-80783",
"name": "Dr Reddy's Laboratories (UK) Ltd"
}
],
"relatedLots": [
"3"
]
}
],
"tender": {
"id": "ocds-h6vhtk-03e1fc",
"lots": [
{
"id": "1",
"title": "NP35923a Apixaban",
"status": "cancelled",
"hasOptions": false,
"description": "Supply of Apixaban tablets in a range of presentations.\nThe Authority will be awarding each product line as a multi-supplier unranked framework agreement to five (5) suppliers awarded to each line.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
}
},
{
"id": "3",
"title": "NP40923a Sugammadex",
"status": "cancelled",
"hasOptions": false,
"description": "Supply of Sugammadex solution for injection vials, in a range of presentations to NHS Scotland.\nThe Authority will be awarding each line to a single Framework Participant within the single supplier Framework Agreement.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
}
},
{
"id": "2",
"title": "NP39723a Bexarotene",
"status": "cancelled",
"hasOptions": false,
"description": "Supply of Bexarotene 75mg capsules to NHS Scotland.\nThe Authority will be awarding the product line to a single Framework Participant within the single supplier Framework Agreement.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
}
},
{
"id": "4",
"title": "NP36123a Atovaquone",
"status": "cancelled",
"hasOptions": false,
"description": "Supply of Atovaquone 750mg/5ml oral suspension sugar free to NHS Scotland.\nThe Authority will be awarding the product line to a single Framework Participant within the single supplier Framework Agreement.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "3",
"relatedLot": "3",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "2",
"relatedLot": "2",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "4",
"relatedLot": "4",
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "NP Generic Medicines Transition Tender (October 2023)",
"status": "complete",
"coveredBy": [
"GPA"
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"techniques": {
"hasFrameworkAgreement": true
},
"description": "This Procurement is for the supply of a range of Generic Medicines to health boards across NHS Scotland. The Goods have been split into four (4) individual Framework Agreements. Full details of each individual Framework Agreement is contained in section II.2 of this notice.",
"reviewDetails": "Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:\nAn economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.\nThe bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.",
"classification": {
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
"procurementMethod": "open",
"mainProcurementCategory": "goods",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-FTS-322",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"roles": [
"buyer",
"centralPurchasingBody"
],
"address": {
"region": "UKM",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"countryName": "United Kingdom",
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent"
},
"details": {
"url": "http://www.nss.nhs.scot/browse/procurement-and-logistics",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
},
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"contactPoint": {
"email": "ruaridh.armitage@nhs.scot",
"telephone": "+44 7804475952"
}
},
{
"id": "GB-FTS-3467",
"name": "Glenmark Pharmaceuticals Europe Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Watford",
"postalCode": "WD18 8YA",
"countryName": "United Kingdom",
"streetAddress": "Building 2, Croxley Green Business Park"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Glenmark Pharmaceuticals Europe Ltd"
},
"contactPoint": {
"telephone": "+44 7538794897"
}
},
{
"id": "GB-FTS-93450",
"name": "Celix Pharma Ltd.",
"roles": [
"supplier"
],
"address": {
"region": "UKI4",
"locality": "London",
"postalCode": "E16 2DQ",
"countryName": "United Kingdom",
"streetAddress": "12 Constance Street, International House"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Celix Pharma Ltd."
},
"contactPoint": {
"telephone": "+44 7795600016"
}
},
{
"id": "GB-FTS-80783",
"name": "Dr Reddy's Laboratories (UK) Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Cambridge",
"postalCode": "CB4 0PE",
"countryName": "United Kingdom",
"streetAddress": "410, Cambridge Science Park,, Milton Road, Milton,"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Dr Reddy's Laboratories (UK) Ltd"
},
"contactPoint": {
"telephone": "+44 7717467751"
}
},
{
"id": "GB-FTS-4567",
"name": "Selective Supplies Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Haywards Heath",
"postalCode": "RH16 3LB",
"countryName": "United Kingdom",
"streetAddress": "The Priory, Syresham Gardens"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Selective Supplies Ltd"
}
},
{
"id": "GB-FTS-93451",
"name": "Teva UK Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Castleford",
"postalCode": "WF10 5HX",
"countryName": "United Kingdom",
"streetAddress": "Ridings Point, Whistler Drive, Glasshoughton"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Teva UK Ltd"
},
"contactPoint": {
"telephone": "+44 7780226334"
}
},
{
"id": "GB-FTS-5073",
"name": "Thornton & Ross",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Huddersfield",
"postalCode": "HD7 5QH",
"countryName": "United Kingdom",
"streetAddress": "Linthwaite"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Thornton & Ross"
}
},
{
"id": "GB-FTS-80784",
"name": "Viatris UK Healthcare Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UKH23",
"locality": "Hatfield",
"postalCode": "AL10 9UL",
"countryName": "United Kingdom",
"streetAddress": "Building 4, Trident Place, Mosquito Way"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Viatris UK Healthcare Ltd"
},
"contactPoint": {
"telephone": "+44 7586494246"
}
},
{
"id": "GB-FTS-324",
"name": "Sheriff Court House",
"roles": [
"reviewBody"
],
"address": {
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"countryName": "United Kingdom",
"streetAddress": "27 Chambers Street"
},
"details": {
"url": "https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court"
},
"identifier": {
"legalName": "Sheriff Court House"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk",
"telephone": "+44 1312252525"
}
}
],
"language": "en",
"contracts": [
{
"id": "028388-2023-1",
"title": "NP35923a Apixaban",
"value": {
"amount": 161316,
"currency": "GBP"
},
"status": "active",
"awardID": "028388-2023-1",
"dateSigned": "2023-09-26T00:00:00+01:00"
},
{
"id": "028388-2023-2",
"title": "NP39723a Bexarotene",
"value": {
"amount": 35022,
"currency": "GBP"
},
"status": "active",
"awardID": "028388-2023-2",
"dateSigned": "2023-09-26T00:00:00+01:00"
},
{
"id": "028388-2023-3",
"title": "NP36123a Atovaquone",
"value": {
"amount": 96219,
"currency": "GBP"
},
"status": "active",
"awardID": "028388-2023-3",
"dateSigned": "2023-09-26T00:00:00+01:00"
},
{
"id": "028388-2023-4",
"title": "NP40923a Sugammadex",
"value": {
"amount": 552685,
"currency": "GBP"
},
"status": "active",
"awardID": "028388-2023-4",
"dateSigned": "2023-09-26T00:00:00+01:00"
}
],
"description": "The estimated values referred to in Section II.1.5 and each Lot section of this Notice cover the forecasted spend for the duration of each individual Framework Agreement.\nFor details of individual lines awarded within a Framework Agreement/Lot contact the named person at head of notice.\n(SC Ref:745745)",
"initiationType": "tender"
}14 Jul 2023 · 020286-2023 · tender
{
"id": "020286-2023",
"tag": [
"tender"
],
"date": "2023-07-14T12:49:12+01:00",
"ocid": "ocds-h6vhtk-03e1fc",
"buyer": {
"id": "GB-FTS-322",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000738823"
}
],
"tender": {
"id": "ocds-h6vhtk-03e1fc",
"lots": [
{
"id": "3",
"title": "NP40923a Sugammadex",
"value": {
"amount": 2539833,
"currency": "GBP"
},
"status": "active",
"hasOptions": false,
"hasRenewal": false,
"description": "Supply of Sugammadex solution for injection vials, in a range of presentations to NHS Scotland.\nThe Authority intends awarding each line to a single Framework Participant within the single supplier Framework Agreement.\nStart Date: 01/10/2023\nEnd Date: 31/01/2026\nFull details of Goods and volumes can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"durationInDays": 840
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "4",
"title": "NP36123a Atovaquone",
"value": {
"amount": 226333,
"currency": "GBP"
},
"status": "active",
"hasOptions": false,
"hasRenewal": false,
"description": "Supply of Atovaquone 750mg/5ml oral suspension sugar free to NHS Scotland.\nThe Authority intends awarding each line to a single Framework Participant within the single supplier Framework Agreement.\nStart Date: 01/10/2023\nEnd Date: 30/04/2024\nFull details of Goods and volumes can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"durationInDays": 210
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "1",
"title": "NP35923a Apixaban",
"value": {
"amount": 2119925,
"currency": "GBP"
},
"status": "active",
"hasOptions": false,
"hasRenewal": false,
"description": "Supply of Apixaban tablets in a range of presentations.\nThe Authority intends awarding each product line as a multi-supplier unranked framework agreement to an envisaged maximum of seven (7) suppliers awarded to each line.\nStart Date: 01/10/2023\nEnd Date: 30/04/2025\nFull details of Goods and volumes can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"durationInDays": 570
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "2",
"title": "NP39723a Bexarotene",
"value": {
"amount": 85900,
"currency": "GBP"
},
"status": "active",
"hasOptions": false,
"hasRenewal": false,
"description": "Supply of Bexarotene 75mg capsules to NHS Scotland.\nThe Authority intends awarding each line to a single Framework Participant within the single supplier Framework Agreement.\nStart Date: 01/10/2023\nEnd Date: 31/01/2025\nFull details of Goods and volumes can be found within the ITT.",
"awardCriteria": {
"criteria": [
{
"name": "API Sources",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"durationInDays": 480
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
}
],
"items": [
{
"id": "3",
"relatedLot": "3",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "4",
"relatedLot": "4",
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "1",
"relatedLot": "1",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "2",
"relatedLot": "2",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "NP Generic Medicines Transition Tender (October 2023)",
"value": {
"amount": 4972000,
"currency": "GBP"
},
"status": "active",
"coveredBy": [
"GPA"
],
"bidOpening": {
"date": "2023-08-14T17:00:00+01:00"
},
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lotDetails": {
"maximumLotsBidPerSupplier": null
},
"techniques": {
"frameworkAgreement": {
"maximumParticipants": null
},
"hasFrameworkAgreement": true
},
"awardPeriod": {
"startDate": "2023-08-14T17:00:00+01:00"
},
"description": "This Procurement is for the supply of a range of Generic Medicines to health boards across NHS Scotland. The Goods have been split into four (4) individual Framework Agreements. Full details of each individual Framework Agreement is contained in section II.2 of this notice.",
"tenderPeriod": {
"endDate": "2023-08-14T17:00:00+01:00"
},
"contractTerms": {
"hasElectronicPayment": true,
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed"
},
"hasRecurrence": false,
"reviewDetails": "The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"classification": {
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"submissionMethod": [
"electronicSubmission"
],
"procurementMethod": "open",
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"appliesTo": [
"supplier"
],
"description": "Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015"
},
{
"type": "technical",
"minimum": "(a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender for the Framework Agreement should be included in the Qualification Envelope of the ITT under Part 4C: Quality Control.\nAND\n(b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under Part 4D: Quality Assurance Schemes.\nAND\n(c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Part 4C: Products.\nAND\n(d) A completed copy of the Bidder Climate Change Plan template, including planned projects and actions to reduce the bidder's carbon emissions must be provided in the Qualification Envelope of the ITT under Environmental Management. This does not need to contain calculated carbon emissions.",
"appliesTo": [
"supplier"
],
"description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender for the Framework Agreement.\nAND\n(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.\nAND\n(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design.\nd) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond."
}
]
},
"mainProcurementCategory": "goods",
"submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-FTS-322",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"roles": [
"buyer",
"centralPurchasingBody"
],
"address": {
"region": "UKM",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"countryName": "United Kingdom",
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent"
},
"details": {
"url": "http://www.nss.nhs.scot/browse/procurement-and-logistics",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
},
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"contactPoint": {
"url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"email": "ruaridh.armitage@nhs.scot",
"telephone": "+44 7804475952"
}
},
{
"id": "GB-FTS-324",
"name": "Sheriff Court House",
"roles": [
"reviewBody"
],
"address": {
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"countryName": "United Kingdom",
"streetAddress": "27 Chambers Street"
},
"details": {
"url": "https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court"
},
"identifier": {
"legalName": "Sheriff Court House"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk",
"telephone": "+44 1312252525"
}
}
],
"language": "en",
"description": "The estimated values referred to in Section II.1.5 and each Lot section of this Notice cover the forecasted spend for the duration of each individual Framework Agreement.\nThe buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 24713. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343\nA sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363\nCommunity benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/\nA summary of the expected community benefits has been provided as follows:\nIt is a mandatory requirement that potential framework participants agree to support the concept, provision and ongoing development of community benefits provision in relation to this framework.\nPotential framework participants are required to agree to this mandatory requirement. They are also requested to provide a brief summary of the community benefits that have recently been delivered within Scotland, if at all, and also what impact and outcomes these have achieved.\nPotential framework participants are required to summarise any proposed community benefits that will be developed and delivered as part of this contract if successful or, alternatively, potential framework participants confirm that they will engage with the NHS Scotland’s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits.\nFor further information please visit NHSS Community Benefit Gateway\n(https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-community-benefit-gateway/).\n(SC Ref:738823)",
"initiationType": "tender"
}